NEW YORK (GenomeWeb News) – BioFire Diagnostics has appointed Robert Lollini as CFO.

Lollini most recently served as CEO, and formerly as CFO of Myrexis, a Utah-based biotechnology company. He remains a member of its board of directors. From 1993 to 2007, Lollini held multiple executive positions at drug-delivery company Iomed, which was acquired in May 2007. Earlier in his career, he held various executive management positions at RP Scherer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.